{"id":1064993,"date":"2011-12-11T16:55:04","date_gmt":"2011-12-11T16:55:04","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/active-phase-iii-or-iiiii-cell-therapy-trials\/"},"modified":"2024-08-18T11:08:30","modified_gmt":"2024-08-18T15:08:30","slug":"active-phase-iii-or-iiiii-cell-therapy-trials","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/regenerative-medicine\/active-phase-iii-or-iiiii-cell-therapy-trials.php","title":{"rendered":"Active phase III or II\/III cell therapy trials"},"content":{"rendered":"
Tweet<\/a> <\/span><\/div>
<\/div>
I know that the moment I publish anything that purports to be comprehensive there will be errors and omissions.  At the very least it will almost imminently be out-of-date in a fast-moving sector like cell therapy.<\/div>
<\/div>
Nonetheless, because there is no other reliable repository of this information, I am daring to put this out there and hope you will feel obligated to assist me in ensuring its accuracy rather than critical of the effort.<\/div>
<\/div>
What follows is what I currently believe to an current and relatively comprehensive list of phase III or II\/III cell therapy trials around the world.  I am more confident of the industry list than the academic one.  More confident of its completeness and accuracy for North American and Europe than of Asia (particularly China).  <\/div>
<\/div>
There is a spreadsheet behind this that includes more data fields like therapeutic category, cell\/tissue source, cell type, expansion, indication, expected completion date, clinical trial site locations, etc.  If you want a copy of it, just email me (I'm not hard to find) or comment below.<\/div>
<\/div>

INDUSTRY PHASE III or II\/III <\/b>(active or expected to be active in 1H 2012)   <\/span><\/p>

        <\/div>
    Aastrom                         Ixmyelocel-T<\/div>
    Baxter                            ACT34-CMI<\/div>
    Bioheart                         Myocell<\/div>
    Cardio3 Biosciences         C-CURE<\/div>
    Cardio3 Biosciences         C-CURE<\/div>
    Cell Medica                     adoptive cellular therapy<\/div>
    Cook Myosite                  AMDC<\/div>
    Cytori                            ADRCs<\/div>
    GamidaCell - Teva           StemEx<\/div>
    Genzyme                        MACI<\/div>
    Harvest Technologies       SmartPReP 2 BMAC<\/div>
    Innovaell                        IES13 (Urocell?)<\/div>
    Kiaidis Pharma                ATIR<\/div>
    Miltenyi                         CliniMACS CD34 Selection System<\/div>
    Medipost                       Cartistem<\/div>
    MolMed                         TK<\/div>
    Newlink Genetics            HyperAcute Pancreas <\/div>
    NovaRx                         Lucanix<\/div>
    Osiris                           Prochymal<\/div>
    Osiris                           Prochymal<\/div>
    Pervasis                        Vasugel<\/div>
<\/div>
The 21 active or imminently active cell therapy industry-sponsored trials listed above break down as follows:<\/div>